Jasper Therapeutics, Inc.
JSPR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.
Other share classesJSPRW
13F holders, Q1 2024
Institutional positions in Jasper Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- +19 vs. Q4 2023
- Shares held
- 13.0M
- −62.5M (−82.7%) vs. Q4 2023
- Total value
- $380.2M
- +$319.0M (+521.3%) vs. Q4 2023
- New holders
- 33
- 2 more added
- Sold out
- 14
- 26 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $5.05M |
| Q1 2026 | 58 | $13.9M |
| Q4 2025 | 55 | $35.2M |
| Q3 2025 | 60 | $47.8M |
| Q2 2025 | 65 | $69.5M |
| Q1 2025 | 69 | $56.1M |
| Q4 2024 | 88 | $334.5M |
| Q3 2024 | 81 | $274.8M |
| Q2 2024 | 69 | $329.8M |
| Q1 2024 | 61 | $380.2M |
| Q4 2023 | 42 | $61.2M |
| Q3 2023 | 41 | $63.7M |
| Q2 2023 | 46 | $120.0M |
| Q1 2023 | 45 | $168.8M |
| Q4 2022 | 23 | $9.57M |
| Q3 2022 | 23 | $15.7M |
| Q2 2022 | 23 | $37.5M |
| Q1 2022 | 24 | $69.6M |
| Q4 2021 | 25 | $160.7M |
| Q3 2021 | 9 | $101.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 10 | $0 | 0.00% | −247−96.1% | Reduced |
| Macquarie Group Ltd | 697 | $20 | 0.00% | +697 | New |
| BFSG, LLC | 10 | $294 | 0.00% | +10 | New |
| National Bank of Canada | 100 | $2.12K | 0.00% | +100 | New |
| Wells Fargo & Company | 92 | $2.70K | 0.00% | −517−84.9% | Reduced |
| Lazard Asset Management LLC | 744 | $21.0K | 0.00% | −10,756−93.5% | Reduced |
| ADAR1 Capital Management, LLC | 2,406 | $70.6K | 0.02% | +2,406 | New |
| Simplex Trading, LLC | 3,758 | $110.0K | 0.00% | +3,732+14,353.8% | Added |
| Citigroup Inc | 7,363 | $216.2K | 0.00% | +7,363 | New |
| Atom Investors LP | 7,373 | $216.5K | 0.03% | +7,373 | New |
| Leonteq Securities AG | 8,000 | $234.9K | 0.03% | +8,000 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 8,002 | $234.9K | 0.06% | +8,002 | New |
| Susquehanna International Group, LLP | 8,084 | $237.3K | 0.00% | +8,084 | New |
| Brevan Howard Capital Management LP | 8,378 | $246.0K | 0.02% | +8,378 | New |
| Balyasny Asset Management LLC | 8,417 | $247.1K | 0.00% | +8,417 | New |
| Cubist Systematic Strategies, LLC | 10,250 | $300.9K | 0.00% | +10,250 | New |
| Virtu Financial LLC | 10,410 | $306.0K | 0.02% | +10,410 | New |
| American Century Companies Inc | 11,172 | $328.0K | 0.00% | +11,172 | New |
| Landscape Capital Management, L.L.C. | 11,397 | $334.6K | 0.03% | −777,934−98.6% | Reduced |
| Marshall Wace, LLP | 13,449 | $394.9K | 0.00% | +13,449 | New |
| Citadel Advisors LLC | 16,210 | $475.9K | 0.00% | −174,945−91.5% | Reduced |
| Man Group plc | 20,357 | $597.7K | 0.00% | +20,357 | New |
| Concurrent Investment Advisors, LLC | 20,409 | $599.2K | 0.02% | +20,409 | New |
| EAM Investors, LLC | 21,525 | $632.0K | 0.10% | +21,525 | New |
| Northern Trust Corp | 22,697 | $666.4K | 0.00% | −132,212−85.3% | Reduced |
| HRT Financial LP | 23,271 | $683.0K | 0.00% | +23,271 | New |
| Boothbay Fund Management, LLC | 23,324 | $684.8K | 0.02% | +23,324 | New |
| Bank of Montreal | 69,100 | $811.9K | 0.00% | −279,200−80.2% | Reduced |
| Lion Point Capital, LP | 32,000 | $939.5K | 1.80% | +32,000 | New |
| Cantor Fitzgerald, L. P. | 35,000 | $1.05M | 0.25% | +35,000 | New |
| State Street Corp | 39,999 | $1.17M | 0.00% | −189,995−82.6% | Reduced |
| Jane Street Group, LLC | 41,894 | $1.23M | 0.00% | +30,685+273.8% | Added |
| LMR Partners LLP | 43,945 | $1.29M | 0.03% | +43,945 | New |
| Fernwood Investment Management, LLC | 49,470 | $1.45M | 0.42% | −445,236−90.0% | Reduced |
| Mariner, LLC | 52,826 | $1.55M | 0.00% | −537,684−91.1% | Reduced |
| Russell Investments Group, Ltd. | 79,811 | $2.34M | 0.00% | +79,811 | New |
| Ikarian Capital, LLC | 105,175 | $3.09M | 0.84% | +105,175 | New |
| Silverarc Capital Management, LLC | 109,892 | $3.23M | 0.90% | +109,892 | New |
| Millennium Management LLC | 111,366 | $3.27M | 0.00% | −18,517−14.3% | Reduced |
| Geode Capital Management, LLC | 127,991 | $3.76M | 0.00% | −776,486−85.8% | Reduced |
| StemPoint Capital LP | 129,211 | $3.79M | 1.01% | +129,211 | New |
| Morgan Stanley | 176,417 | $5.18M | 0.00% | −1,523,133−89.6% | Reduced |
| BlackRock Inc. | 193,422 | $5.68M | 0.00% | −1,130,550−85.4% | Reduced |
| Ally Bridge Group (NY) LLC | 289,943 | $8.51M | 4.73% | −3,369,312−92.1% | Reduced |
| Bank of America Corp | 319,787 | $9.39M | 0.00% | −2,860,272−89.9% | Reduced |
| Boxer Capital, LLC | 350,000 | $10.3M | 0.51% | +350,000 | New |
| Woodline Partners LP | 379,246 | $11.1M | 0.10% | −1,353,747−78.1% | Reduced |
| Rock Springs Capital Management LP | 404,335 | $11.9M | 0.30% | +404,335 | New |
| Great Point Partners LLC | 407,550 | $12.0M | 1.86% | +407,550 | New |
| Opaleye Management Inc. | 435,573 | $12.8M | 2.79% | −3,549,767−89.1% | Reduced |
| Kingdon Capital Management, L.L.C. | 497,000 | $14.6M | 1.93% | −3,043,000−86.0% | Reduced |
| Octagon Capital Advisors LP | 500,811 | $14.7M | 1.79% | −3,967,303−88.8% | Reduced |
| Sphera Funds Management Ltd. | 505,242 | $14.8M | 2.40% | −207,821−29.1% | Reduced |
| Samsara BioCapital, LLC | 525,000 | $15.4M | 2.38% | +525,000 | New |
| Vanguard Group Inc | 612,745 | $18.0M | 0.00% | −3,480,213−85.0% | Reduced |
| Franklin Resources Inc | 722,074 | $21.2M | 0.01% | +722,074 | New |
| Avidity Partners Management LP | 760,000 | $22.3M | 0.79% | +760,000 | New |
| Qiming U.S. Ventures Management, LLC | 928,964 | $27.3M | 30.41% | −7,590,684−89.1% | Reduced |
| Carlyle Group Inc. | 1,066,189 | $31.3M | 1.97% | −7,695,702−87.8% | Reduced |
| Soleus Capital Management, L.P. | 1,187,096 | $34.9M | 3.06% | −8,683,884−88.0% | Reduced |
| Velan Capital Investment Management LP | 1,471,904 | $42.1M | 22.76% | −9,747,132−86.9% | Reduced |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −2,228,265−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −1,386,215−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −514,324−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −249,563−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −54,500−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −54,168−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −43,593−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −36,899−100.0% | Sold out |
| Gries Financial LLC | 0 | $0 | 0.00% | −23,845−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −11,144−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |